Meeting
2021 ASCO Annual Meeting
Patient-reported quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: Interim results of the TALLISUR study.
Authors
Meinolf Karthaus
Klinikum Neuperlach/Harlaching, Munich, Germany
Meinolf Karthaus , Albrecht Kretzschmar , Stefan Fuxius , Jorge Riera Knorrenschild , Florian Kaiser , Rolf Mahlberg , Manfred Welslau , Henning Pelz , Volker Heinemann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
No 2017-000292-83
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3526)
DOI
10.1200/JCO.2021.39.15_suppl.3526
Abstract #
3526
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Evaluation of health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC): A prospective, multicenter, open-label, double-arm trial of trifluridine/tipiracil (FTD/TPI) versus best supportive care (BSC).
First Author: Meinolf Karthaus
Poster
2019 Gastrointestinal Cancers Symposium
Validation of cost-effectiveness of trifluridine/tipiracil versus best supportive care and regorafenib for previously treated metastatic colorectal cancer in the UK using phase IIIb PRECONNECT early access clinical trial data in the real world setting.
First Author: Javier Sabater
Poster
2023 ASCO Annual Meeting
Trifluridine/tipiracil (FTD/TPI) in extensively pre-treated metastatic colorectal cancer (mCRC) patients: Evaluation of prognostic subgroups of the TALLISUR study.
First Author: Meinolf Karthaus
Poster
2020 Gastrointestinal Cancers Symposium
Exploratory analysis of trifluridine/tipiracil in late-stage metastatic colorectal cancer (mCRC): Prognostic factors.
First Author: Meinolf Karthaus